Inspire Medical Systems, Inc. vs Pfizer, Inc. — Stock Comparison
Inspire Medical Systems, Inc. (INSP) and Pfizer, Inc. (PFE) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Inspire Medical Systems, Inc. narrowly edges Pfizer, Inc. on Q·Score (7 vs 6.4 out of 10), led by Health (9.7 vs 7) and Quality (8 vs 6.4). Pfizer, Inc. scores higher on Valuation, reflecting stronger P/E and price-target positioning. Analyst consensus targets imply greater upside for INSP (+22.4%) than for PFE (+15.8%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
Clean balance sheet with low leverage (0.0× debt-to-equity).
⚠ cautious analyst consensus — few Buy ratings.
Forward P/E of 8.9× is low relative to sector peers.
⚠ earnings contracting 10% year-over-year.
Analyst Consensus
Fundamentals
Frequently Asked Questions
INSP vs PFE: which stock scores better overall?
Based on Q·Score, Inspire Medical Systems, Inc. (INSP) scores 7/10 versus Pfizer, Inc. (PFE) at 6.4/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: INSP or PFE?
Inspire Medical Systems, Inc. (INSP) scores higher on Growth (6.2/10 vs 5.1/10). Inspire Medical Systems, Inc. reports revenue growth (1.6% YoY) while Pfizer, Inc. reports (5.4% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is INSP or PFE more attractively valued?
Pfizer, Inc. (PFE) scores higher on Valuation (7.7/10 vs 6/10). INSP trades at 32.6× P/E versus PFE at 8.9×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about INSP vs PFE?
There are 12 analysts covering INSP with a consensus price target of $52.17, and 27 analysts covering PFE with a consensus target of $29.19. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: INSP or PFE?
Inspire Medical Systems, Inc. (INSP) scores higher on Quality (8/10 vs 6.4/10). Net profit margin: INSP at 14.3%, PFE at 11.8%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: INSP or PFE?
Inspire Medical Systems, Inc. (INSP) scores higher on Financial Health (9.7/10 vs 7/10). Market beta: INSP at 0.73, PFE at 0.29. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of INSP and PFE?
Inspire Medical Systems, Inc. (INSP) has a market capitalisation of $1.2B, while Pfizer, Inc. (PFE) has a market cap of $143.7B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do INSP or PFE pay dividends?
INSP does not currently pay a dividend, while PFE pays a dividend yield of 6.61%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →